Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 118 | +16 |
| Shares | 33.6M | 18.7K | 34.1M | +556.1K (+1.7%) |
| Value | $620.0M | $349.0K | $521.7M | −$98.0M (−15.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (9)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Eventide Asset Management, LLC | 1,490,000 | $27.7M |
| UBS Asset Management Americas Inc | 319,090 | $5.94M |
| Granite Point Capital Management, L.P. | 110,000 | $2.05M |
| The PNC Financial Services Group, Inc. | 45,722 | $851.0K |
| Quantitative Systematic Strategies LLC | 12,343 | $230.0K |
| Vident Investment Advisory, LLC | 11,731 | $218.0K |
| Acadian Asset Management LLC | 2,365 | $44.0K |
| Group One Trading, L.P. | 890 | $17.0K |
| Barclays PLC | 40 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Elmwood Wealth Management, Inc. | 18,729 | $349.0K |